索通發展(603612.SH):若干董事及高管擬減持不超73.67萬股
格隆匯8月4日丨索通發展(603612.SH)公佈,獲知悉副董事長張新海,董事、總經理郝俊文,董事、副總經理劉瑞,董事荊昇陽,副總經理、財務總監郎靜,副總經理、董事會祕書袁鋼,總工程師李軍,副總經理範本勇,副總經理李建寧,副總經理黃河等人員集中競價減持股份計劃:
因個人資金需求,以上人員中張新海、荊昇陽擬自2021年8月26日至2021年12月31日、其他人員擬自2021年9月10日至2021年12月31日按規定在不超過其所持公司股份25%的範圍內實施減持,減持價格按市場價格確定。
上述董事、高級管理人員計劃減持總股數不超過73.665萬股,不超過目前公司總股本的0.1604%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.